IPO Issue Details
Issue Price / Price Band₹68 per share (Fixed Price)
Face Value₹10 Per Share
Lot Size2,000 Shares per Lot
Total Issue Size65,70,000 shares (aggregating up to ₹44.68 Cr)
Issue TypeBookbuilding IPO
Sale Type / CategoryFresh Capital-cum-Offer for Sale
Exchange / PlatformNSE SME
IPO TypeSME
Subscription OpenThu, 04 Jul 2024
Subscription CloseMon, 08 Jul 2024
Anchor AllotmentWed, 03 Jul 2024
Basis of AllotmentTue, 09 Jul 2024
Initiation of RefundsWed, 10 Jul 2024
Credit of Shares to DematWed, 10 Jul 2024
Listing DateThu, 11 Jul 2024
UPI Mandate Deadline2024-07-08
Application & Investment Details
Retail — Min (1 Lots)₹1,36,000 — 2,000 shares
Retail — Max (13 Lots)₹1,768,000 (13 Lots)
HNI — Min (2 Lots)₹2,72,000 — 4,000 shares
EPS (Pre-IPO)₹2.44
EPS (Post-IPO)₹2.89
P/E Ratio (Pre-IPO)27.81x
P/E Ratio (Post-IPO)23.54x
Net Offer to Public62,40,000 shares (aggregating up to ₹42.43 Cr)
Reserved for Market Maker3,30,000 shares (aggregating up to ₹2.24 Cr)
Pre-IPO Promoter Holding1,86,88,819 shares
Post-IPO Promoter Holding2,52,58,819 shares
Fresh Issue Shares59,28,000 shares (aggregating up to ₹40.31 Cr)
Offer for Sale Shares3,12,000 shares of ₹10 (aggregating up to ₹2.12 Cr)
About Ambey Laboratories Ltd.
Ambey Laboratories, incorporated in 1985, manufactures agrochemical products for crop protection. The company has been serving the agrochemical sector for almost four decades.The company manufactures and supplies 2,4-D base chemicals.The company's manufacturing facility in Behror, Rajasthan, is certified with ISO 9001:2015 by the Quality Research Organization and ISO 14001:2015 by the United Accreditation Foundation.The company currently produces the following products for its customer base, which includes large corporates like Aromatic Rasayan Private Limited, JR Jindal Infraprojects Private Limited, and SC Formulator Co. Ltd:2,4-D Acid 98% TC2,4-D Sodium 95% SP2,4-D Amine 866 | 720 | 480g/l SL2,4-D Ethyl Hexyl Ester 96% TC2,4-D Ethyl Ester 96% TCChlorpyriphos 97%TC / 20%EC / 50%ECThiamethoxam 96%TC / 25%WG / 75%SGPretilachlor 95%TC / 50%EC / 37%EWMetribuzin 97%TC / 70%WSHexaconazole 92%TC / 5%SC / 5%EC / 10%ECMetalaxyl 98%TC / 35%WS As of October 31, 2023 the company employs 220 people in various departments.
Objects of the Issue
Ambey Laboratories Ltd. proposes to utilise the net proceeds from the Issue for the following objects:
1
To meet Working Capital Requirements
2
General corporate purposes
Shareholding & Lock-in
Pre-IPO Promoter Holding
1,86,88,819 shares
Post-IPO Promoter Holding
2,52,58,819 shares